1 mTORC 1 inhibition activates PI 3 K / Akt by up-regulating IGF-1 R signaling in acute myeloid leukemia : rational for therapeutic inhibition of both pathways

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Constitutive phosphoinositide 3-kinase/Akt activation represents a favorable prognostic factor in de novo acute myelogenous leukemia patients.

  2007cited by this paper
• Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB.

  2006cited by this paper
• Single cell analysis of phosphoinositide 3-kinase/Akt and ERK activation in acute myeloid leukemia by flow cytometry.

  2006cited by this paper
• A selective inhibitor of the p110delta isoform of PI 3-kinase inhibits AML cell proliferation and survival and increases the cytotoxic effects of VP16.

  2006cited by this paper
• Antileukemic activity of rapamycin in acute myeloid leukemia.

  2005cited by this paper
• Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes.

  2005cited by this paper
• Essential role for the p110delta isoform in phosphoinositide 3-kinase activation and cell proliferation in acute myeloid leukemia.

  2005cited by this paper
• mTOR regulates cell survival after etoposide treatment in primary AML cells.

  2005cited by this paper
• The Akt-mTOR tango and its relevance to cancer.

  2005cited by this paper
• Upstream and downstream of mTOR.

  2004cited by this paper
• Balancing Akt with S6K

  2004cited by this paper
• The TSC1-2 tumor suppressor controls insulin–PI3K signaling via regulation of IRS proteins

  2004cited by this paper
• Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies.

  2004cited by this paper
• Inhibition of phosphatidylinositol 3-kinase dephosphorylates BAD and promotes apoptosis in myeloid leukemias

  2004cited by this paper
• Constitutive phosphorylation of Akt/PKB protein in acute myeloid leukemia: its significance as a prognostic variable

  2003cited by this paper
• Survival of acute myeloid leukemia cells requires PI3 kinase activation.

  2003cited by this paper
• Monoclonal antibody to the type I insulin-like growth factor (IGF-I) receptor blocks IGF-I receptor-mediated DNA synthesis: clarification of the mitogenic mechanisms of IGF-I and insulin in human skin fibroblasts.

  1986cited by this paper

• Targeting the PI3K/Akt/mTOR pathway: effective combinations and clinical considerations.

  2008cites this paper
• PI-103, a dual inhibitor of Class IA phosphatidylinositide 3-kinase and mTOR, has antileukemic activity in AML

  2008cites this paper
• Targeting receptor tyrosine kinase signaling in acute myeloid leukemia.

  2007cites this paper